Home / SMSPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SMSPHARMA.NS make money? Does SMSPHARMA.NS have pricing power? What's the Earnings Whisper? Will SMSPHARMA.NS profit more as the business scales? What is SMSPHARMA.NS's management track record? Is SMSPHARMA.NS's current price justified?

SMS Pharmaceuticals Limited

₹450.5 +$137.05 (+43.72%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹424.95

Day Range

₹423.2₹458.5

Year Range

₹270.1₹494.45

Market Cap

42.19B

AVG Volume

617.83K

Trailing/Forward PE

40.08/-

PEG ratio

1.26

Dividend Yield

0.09%

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

SMSPHARMA.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	2.09B
26 Q4	2.38B
26 Q3	2.1B
26 Q2	2.42B
26 Q1	1.96B
25 Q4	2.48B
25 Q3	1.73B
25 Q2	1.97B
25 Q1	1.64B
24 Q4	2.46B

Net Income (INR) · Q

SMSPHARMA.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	209.09M
26 Q4	327.14M
26 Q3	234.72M
26 Q2	253.13M
26 Q1	204.91M
25 Q4	203.15M
25 Q3	182.42M
25 Q2	140.99M
25 Q1	164.79M
24 Q4	172.79M

Operating Income (INR) · Q

SMSPHARMA.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	531.36M
26 Q4	297.69M
26 Q3	336.3M
26 Q2	383.44M
26 Q1	296.17M
25 Q4	321.66M
25 Q3	245.14M
25 Q2	228.45M
25 Q1	251.3M
24 Q4	269.25M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

SMS Pharmaceuticals Limited

Video analysis: SMSPHARMA.NS

News: SMSPHARMA.NS

Similar companies